Juanjuan Huang

Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)

C. Zhou, Yi‐Long Wu, G. Chen et al. · Annals of Oncology · 2015 · 464 citations

Non-small-cell Lung Cancer, Medicine, Pathology +8

Severity Detection for the Coronavirus Disease 2019 (COVID-19) Patients Using a Machine Learning Model Based on the Blood and Urine Tests

Haochen Yao, Nan Zhang, Ruochi Zhang et al. · Frontiers in Cell and Developmental Biology · 2020 · 129 citations · Full text

Intelligent Diagnostics, Diagnosis, Disease Detection +17

PagERF16 of Populus Promotes Lateral Root Proliferation and Sensitizes to Salt Stress

Shengji Wang, Juanjuan Huang, Xingdou Wang et al. · Frontiers in Plant Science · 2021 · 34 citations · Full text

Effect of local anesthetic volume (20 mL vs 30 mL ropivacaine) on electromyography of the diaphragm and pulmonary function after ultrasound-guided supraclavicular brachial plexus block: a randomized controlled trial

Xiuxia Bao, Juanjuan Huang, Haorong Feng et al. · Regional Anesthesia & Pain Medicine · 2019 · 32 citations

Cisplatin Nanoparticles Promote Intratumoral CD8⁺ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk

Haochen Yao, Na Shen, Guofeng Ji et al. · Nano Letters · 2022 · 28 citations